Published in Gene Therapy Weekly, September 1st, 2005
"The nm23 gene was initially cloned as a metastasis suppressor gene, but the clinical relevance of nm23 as a metastasis suppressor or prognostic indicator for human cancers remain controversial. To evaluate the role of nm23 protein as a prognostic factor and its role in parathyroid neoplasia, we studied nm23 protein expression by immunohistochemical staining in parathyroid lesions," researchers in Saudi Arabia reported.
"Immunohistochemistry using the avidin-biotin peroxidase complex technique with a polyclonal antibody against the nm23 protein was applied to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly